Virtualman offers an AI-Driven Drug Development (ADDD) platform aimed at optimizing the drug development process. Backed by profound expertise in pharmaceutics and AI technologies, the platform expedites the optimization of various drug parameters, producing tailored models within a few weeks. With features like automatic multi-parameter optimization and in-vitro and in-vivo testing managed by AI and expert scientists, it ensures robust and reliable outcomes. The solution presently boasts achievements like over 1161 compounds with low toxicity and high bioavailability. Additional services include ICH M7 impurities assessment with QSAR models and expert reviews for registration purposes.
- Customizable Optimization Models - The platform develops unique automatic multi-parameter optimization models according to your desired properties, within a period of 10 working days up to a few weeks.
- Comprehensive In-Vitro & In-Vivo Testing - Designed and overseen by scientists, the platform conducts real-world tests to ensure reliability of results.
- Impurities Assessment - It offers an additional service of assessing impurities as per ICH M7 regulations using QSAR models and expert reviews.
- Notable Achievements - The platform has produced more than 1161 compounds with low toxicity and high bioavailability, establishing its proficiency.
- Holistic Drug Development - From initial compound expansion to synthesis and selection, the platform supports a comprehensive drug development process.
Virtualman offers an AI-Driven Drug Development (ADDD) platform aimed at optimizing the drug development process. Backed by profound expertise in pharmaceutics and AI technologies, the platform expedites the optimization of various drug parameters, producing tailored models within a few weeks. With features like automatic multi-parameter optimization and in-vitro and in-vivo testing managed by AI and expert scientists, it ensures robust and reliable outcomes. The solution presently boasts achievements like over 1161 compounds with low toxicity and high bioavailability. Additional services include ICH M7 impurities assessment with QSAR models and expert reviews for registration purposes.
- Customizable Optimization Models - The platform develops unique automatic multi-parameter optimization models according to your desired properties, within a period of 10 working days up to a few weeks.
- Comprehensive In-Vitro & In-Vivo Testing - Designed and overseen by scientists, the platform conducts real-world tests to ensure reliability of results.
- Impurities Assessment - It offers an additional service of assessing impurities as per ICH M7 regulations using QSAR models and expert reviews.
- Notable Achievements - The platform has produced more than 1161 compounds with low toxicity and high bioavailability, establishing its proficiency.
- Holistic Drug Development - From initial compound expansion to synthesis and selection, the platform supports a comprehensive drug development process.